Senseonics Holdings Announces Data From Eversense Post Approval Study To Be Presented At 17th International Conference On Advanced Technologies And Treatments for Diabetes
Senseonics Holdings宣佈Eversense批准後研究的數據將在第17屆糖尿病先進技術和治療國際會議上公佈
Senseonics Holdings Announces Data From Eversense Post Approval Study To Be Presented At 17th International Conference On Advanced Technologies And Treatments for Diabetes
Senseonics Holdings宣佈Eversense批准後研究的數據將在第17屆糖尿病先進技術和治療國際會議上公佈
使用瀏覽器的分享功能,分享給你的好友吧